MedDataX Logo

Weight Gain Recommendations for Chinese Women With Gestational Diabetes Mellitus

NCT ID: NCT04421053

Last Updated: 2021-10-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

4050 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-03-24

Study Completion Date

2022-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The 2009 IOM recommendation value for weight gain during pregnancy is widely used. Due to the unclear relationship between gestational diabetes mellitus and weight gain during pregnancy when formulating this recommendation value, pregnant women with gestational diabetes mellitus were excluded from the study population. Control of appropriate weight gain and control of blood glucose stability is an important part of GDM management in pregnant women. The incidence of GDM in China is about 15%-20%, and the number of pregnant women with GDM ranks first in the world. For the sake of the current and long-term health of maternal and infant, it is of great significance to explore the appropriate weight gain range and formulate the recommended value for GDM pregnant women as an independent population. This project intends to use prospective cohort study of combining the observation of pregnant women with gestational diabetes blood sugar and weight changes, through the comparison of normal pregnant women suitable scope of weight gain, analyzes its influence on adverse pregnancy outcomes, increased the weight of gestational diabetes women recommended value is put forward, and combined with the Delphi expert consultation method for evaluation.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This project is a prospective cohort study designed to investigated the changes in blood glucose and body weight in women with gestational diabetes during pregnancy. The study aimed to enroll 4000 participants, using health management app in addition to routine prenatal care. Researchers screen subjects strictly according to the exclusion and inclusion criteria and those who interested sign the informed consent. participants completed baseline questionnaire and dietary questionnaire at app under the instruction of researchers. Pregnant women come back for follow up-visit every 2 weeks until delivery. If anyone doesn't upload the weight data for a week and doesn't respond to the phone call from the researchers, she will be regarded as lost follow-up,the number of lost follow-up cases are supplemented by increasing the enrollment. Data analysis and result output finally.

Besides, part of the study conducted in Beijing has some special points which don't exsit in large cohort study: participants equipment dynamic blood glucose monitor for glycemic control and their blood samples and stool samples will be collected at 24-28, 32 and 36 gestational weeks,respectively.

Based on the description of weight gain range of pregnant women with normal blood glucose, the influence of weight gain on adverse pregnancy outcome was analyzed, and the recommended weight gain value for women with gestational diabetes was proposed in combination with Delphi expert consultation method.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Gestational Diabetes Gestational Weight Gain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

women with GDM

After participants enrollment, we conducted follow-up visit every two weeks. Blood glucose values, body weight, life style record and clinical information are collected. Blood samples and stool samples are collected from participants in Beijing.

prenatal care for women with GDM

Intervention Type BEHAVIORAL

we conduct prenatal care for GDM pregnancies through both prenatal clinic and app.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

prenatal care for women with GDM

we conduct prenatal care for GDM pregnancies through both prenatal clinic and app.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Pregnant women who have regular labor inspection and delivery in the labor inspection hospital;
* Pregnant women with gestational diabetes diagnosed by OGTT at 24 to 28 weeks of pregnancy;
* Singleton pregnancy;
* Those who can skillfully use mobile phones and other electronic devices for scientific follow-up and voluntarily record their daily weight;
* Voluntary signing of informed consent.

Exclusion Criteria

* Patients with pre-pregnancy diabetes mellitus or abnormal OGTT screening in early pregnancy;
* diabetic ketoacidosis,high blood sugar of high permeability anemia,leukemia, and lymphoma without clinical control.
Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Peking Union Medical College Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Liangkun Ma

Role: STUDY_CHAIR

Chinese Academy of Medical Science & Peking Union Medical College Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Department of ob gyn, Peking Union Medical College Hospital

Beijing, Beijing Municipality, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Liangkun Ma

Role: CONTACT

[email protected]
13021961166

Ying Tian

Role: CONTACT

[email protected]
13121591988

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Liangkun Ma, MD

Role: primary

[email protected]
+8613021961166

Ying Tian

Role: backup

[email protected]
15110790115

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

JS-2333

Identifier Type: -

Identifier Source: org_study_id